Form 4: Collegium Pharmaceutical EVP Thomas B. Smith Sells Shares
SEC Filing
EVP and Chief Medical Officer of Collegium Pharmaceutical, Thomas B. Smith, sold 9,593 shares of common stock on September 13, 2024.
Summary
- On September 13, 2024, Thomas B. Smith, the EVP and Chief Medical Officer of Collegium Pharmaceutical, sold 9,593 shares of common stock.
- The sale was executed at a weighted average price of $36.6225 per share, with individual transaction prices ranging from $36.56 to $36.98.
- Following the transaction, Smith directly owns 53,816 shares of Collegium Pharmaceutical.
- The sale was reported on a Form 4 filing with the Securities and Exchange Commission on September 17, 2024.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of an insider transaction. The sale itself doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This is a routine disclosure of an insider stock sale. It's common for executives to periodically sell shares for personal financial management.
Stakeholder Impact
- The sale of shares by an executive could be perceived neutrally or slightly negatively by shareholders, depending on the context and reasons for the sale.
Key Dates
| Date | Description |
|---|---|
| 09/13/2024 | Date of the stock sale transaction. |
| 09/17/2024 | Date the Form 4 was filed with the SEC. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.